Vaxcyte, Inc. (PCVX)

HEALTH CARE: PHARMACEUTICALS
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

353 HATCH DR FOSTER CITY, CA 94404

Vaxcyte is a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide. The Company’s cell-free protein synthesis platform, comprising the XpressCFTM platform, exclusively licensed from Sutro Biopharma, Inc., together with Vaxcyte’s proprietary know-how, enables the design and production of protein carriers and antigens, the critical building blocks of vaccines, in ways that the Company believes conventional vaccine technologies currently cannot. Vaxcyte’s lead vaccine candidate, VAX-24, is a preclinical, 24-valent broad-spectrum pneumococcal conjugate vaccine (PCV) being developed for the prevention of invasive pneumococcal disease (IPD). Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of at least 30 strains, including newly emerging strains responsible for IPD and antibiotic resistance; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease by targeting the keystone pathogen responsible for this chronic, oral inflammatory disease.

Data as of 2021-02-27 11:31:52 -0500
Market Cap1.2 Billion Shares Outstanding50.95 Million Avg 30-day Volume438.741 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE-9.12 Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.0 52-week High/Low58.48 / 17.8 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from PCVX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 4 6 -33.33% 1 (0.06%) 2 (0.12%) -50.0%
Funds Holding: 80 60 33.33% 23 (1.39%) 18 (1.12%) 27.78%
13F shares: 38.046 Million 37.742 Million 0.81% 10.451 Million 11.124 Million -6.05%
% Ownership 74.6735 74.0768 0.81% 20.5123 21.8329 -6.05%
New Positions: 26 34 -23.53% 7 7 0.0%
Increased Positions 28 7 300.0% 7 2 250.0%
Closed Positions 5 12 -58.33% 2 9 -77.78%
Reduced Positions 14 11 27.27% 5 6 -16.67%
Total Calls
Total Puts
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Vaxcyte, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

WhaleWisdom Alpha

Our Other Reporting & Analysis

Funds Holding PCVX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding PCVX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

873 Thousand total shares from 58 transactions

Exercise Derivative Conversion (M)

55.5 Thousand total shares from 10 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

FAIRMAN JEFF VP, RESEARCH

  • Officer
 404,644 2021-02-26 3

PICKERING GRANT PRESIDENT & CEO

  • Officer
  • Director
 1,398,166 2021-02-22 4

WASSIL JIM CHIEF OPERATING OFFICER

  • Officer
 262,307 2021-02-22 2

WRIGHT-MITCHELL JANE GENERAL COUNSEL

  • Officer
 1,562 2021-02-16 2

SAUER PAUL SVP PROCESS DEV, MANUFACTURING

  • Officer
 77,899 2021-02-11 2

HOPFNER ROBERT LORNE

  • Director
 1,405,418 2021-02-08 10

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNERFORMER 10% OWNERFORMER 10% OWNER
 5,074,574 2020-12-15 1

NEWELL WILLIAM J

  • Director
 66,684 2020-12-09 2

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL HEALTHCARE FUND LP

KOLCHINSKY PETER

SHAH RAJEEV M.

  • 10% Owner
 5,001,593 2020-10-07 3

EMSTER KURT VON

  • Director
 4,168,718 2020-06-16 3

HERON PATRICK J

  • Director
 2,309,554 2020-06-16 2

ABINGWORTH LLP

  • 10% Owner
 0 2020-06-11 2

LUKATCH HEATH

  • Director
 0 2020-06-11 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-02 17:37:55 -0500 2021-02-26 S 1,372 $24.34 d 1,476 direct yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-02 17:37:55 -0500 2021-02-26 M 4,750 d 12,009 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-02 17:37:55 -0500 2021-02-26 S 3,310 $23.73 d 2,848 direct yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-02 17:37:55 -0500 2021-02-26 S 68 $25.33 d 1,408 direct yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-03-02 17:37:55 -0500 2021-02-26 M 4,750 $0.04 a 6,158 direct

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-02-24 16:25:59 -0500 2021-02-22 M 3,000 d 245,926 direct

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-02-24 16:25:59 -0500 2021-02-22 M 3,000 $2.42 a 19,381 direct

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-02-24 16:23:09 -0500 2021-02-22 S 8,364 $26.27 d 585,327 direct yes

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-02-24 16:25:59 -0500 2021-02-22 S 1,801 $26.99 d 16,381 direct yes

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-02-24 16:23:09 -0500 2021-02-22 M 15,000 d 463,815 direct

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-02-24 16:23:09 -0500 2021-02-22 M 15,000 $1.79 a 593,691 direct

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-02-24 16:25:59 -0500 2021-02-22 S 1,199 $26.43 d 18,182 direct yes

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-02-24 16:23:09 -0500 2021-02-22 S 6,636 $26.72 d 578,691 direct yes

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-02-17 16:55:29 -0500 2021-02-16 M 2,500 d 202,468 direct

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-02-17 16:55:29 -0500 2021-02-16 S 2,500 $26.95 d 1,562 direct yes

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-02-17 16:55:29 -0500 2021-02-16 M 2,500 $2.03 a 4,062 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-02-16 19:46:05 -0500 2021-02-11 M 2,500 d 23,926 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-02-16 19:46:05 -0500 2021-02-11 M 2,500 $1.79 a 80,399 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-02-16 19:46:05 -0500 2021-02-11 S 316 $27.27 d 77,899 direct yes

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-02-16 19:46:05 -0500 2021-02-11 S 2,184 $26.56 d 78,215 direct yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-10 S 26,688 $26.78 d 1,419,617 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-10 S 6,632 $28.66 d 1,405,418 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-10 S 37,271 $25.75 d 1,446,305 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-10 S 7,567 $27.64 d 1,412,050 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-09 S 88,756 $28.07 d 1,577,316 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-09 S 38,248 $27.12 d 1,666,072 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-09 S 93,740 $28.75 d 1,483,576 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-08 S 50,874 $25.64 d 1,733,242 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-10 19:22:24 -0500 2021-02-08 S 28,922 $26.06 d 1,704,320 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-04 20:51:32 -0500 2021-02-03 S 2,768 $25.06 d 1,784,116 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-04 20:51:32 -0500 2021-02-02 S 14,234 $25.13 d 1,786,884 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-02-02 12:17:11 -0500 2021-01-28 S 2,000 $25.07 d 1,801,118 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-27 18:02:17 -0500 2021-01-27 S 2,140 $25.30 d 1,803,118 indirect yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-01-28 16:36:58 -0500 2021-01-26 S 4,325 $25.20 d 1,833 direct yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-27 18:02:17 -0500 2021-01-26 S 1,373 $26.13 d 1,805,258 indirect yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-01-28 16:36:58 -0500 2021-01-26 M 4,750 d 16,759 direct

FAIRMAN JEFF - Officer VP, RESEARCH

2021-01-28 16:36:58 -0500 2021-01-26 M 4,750 $0.04 a 6,158 direct

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-27 18:02:17 -0500 2021-01-26 S 16,769 $25.23 d 1,806,631 indirect yes

FAIRMAN JEFF - Officer VP, RESEARCH

2021-01-28 16:36:58 -0500 2021-01-26 S 425 $25.94 d 1,408 direct yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-27 18:02:17 -0500 2021-01-25 S 19,511 $25.61 d 1,838,861 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-27 18:02:17 -0500 2021-01-25 S 15,461 $26.07 d 1,823,400 indirect yes

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-22 18:10:12 -0500 2021-01-22 S 11,383 $25.16 d 1,858,372 indirect yes -5.2147 -5.0613 0.0 1 -7.5153 4

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-22 18:10:12 -0500 2021-01-21 S 100 $25.11 d 1,869,755 indirect yes -5.2147 -5.0613 0.0 1 -7.5153 4

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-01-21 19:12:38 -0500 2021-01-20 S 3,000 $25.50 d 16,381 direct yes 3.7391 -2.4264 3.7391 2 -4.0573 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-22 18:10:12 -0500 2021-01-20 S 19,046 $25.35 d 1,869,855 indirect yes -5.2147 -5.0613 0.0 1 -7.5153 4

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-01-21 19:12:38 -0500 2021-01-20 M 3,000 $2.42 a 19,381 direct 3.7391 -2.4264 3.7391 2 -4.0573 5

WASSIL JIM - Officer CHIEF OPERATING OFFICER

2021-01-21 19:12:38 -0500 2021-01-20 M 3,000 d 248,926 direct

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-01-21 18:58:41 -0500 2021-01-19 S 1,567 $25.87 d 578,691 direct yes 3.7391 -2.4264 3.7391 2 -4.0573 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-19 21:07:22 -0500 2021-01-19 S 7,000 $26.05 d 1,888,901 indirect yes -4.2088 -0.607 5.5443 4 -4.2088 2

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-01-21 18:58:41 -0500 2021-01-19 S 13,433 $25.01 d 580,258 direct yes 3.7391 -2.4264 3.7391 2 -4.0573 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-19 21:07:22 -0500 2021-01-19 S 42,516 $25.55 d 1,895,901 indirect yes -4.2088 -0.607 5.5443 4 -4.2088 2

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-01-21 18:58:41 -0500 2021-01-19 M 15,000 d 478,815 direct

PICKERING GRANT - Director - Officer PRESIDENT & CEO

2021-01-21 18:58:41 -0500 2021-01-19 M 15,000 $1.79 a 593,691 direct 3.7391 -2.4264 3.7391 2 -4.0573 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-19 21:07:22 -0500 2021-01-15 S 22,869 $25.74 d 1,942,225 indirect yes -4.2088 -0.607 5.5443 4 -4.2088 2

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-01-19 18:29:14 -0500 2021-01-15 S 2,500 $26.00 d 1,562 direct yes -4.2088 -0.607 5.5443 4 -4.2088 2

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-01-19 18:29:14 -0500 2021-01-15 M 2,500 $2.03 a 4,062 direct -4.2088 -0.607 5.5443 4 -4.2088 2

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-19 21:07:22 -0500 2021-01-15 S 3,808 $26.05 d 1,938,417 indirect yes -4.2088 -0.607 5.5443 4 -4.2088 2

WRIGHT-MITCHELL JANE - Officer GENERAL COUNSEL

2021-01-19 18:29:14 -0500 2021-01-15 M 2,500 d 204,968 direct

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-19 21:07:22 -0500 2021-01-14 S 14,918 $25.88 d 1,965,094 indirect yes -4.2088 -0.607 5.5443 4 -4.2088 2

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-13 S 26,010 $25.90 d 1,983,112 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-13 S 3,100 $26.34 d 1,980,012 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-12 S 901 $27.05 d 2,009,122 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-12 S 17,666 $26.35 d 2,010,023 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-11 S 12,206 $27.02 d 2,027,689 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-01-12 21:43:01 -0500 2021-01-11 M 2,500 d 26,426 direct

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-01-12 21:43:01 -0500 2021-01-11 M 2,500 $1.79 a 80,399 direct 0.1163 -8.2558 0.1163 2 -8.2558 6

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-11 S 24,980 $26.69 d 2,039,895 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-01-12 21:43:01 -0500 2021-01-11 S 1,527 $26.74 d 77,899 direct yes 0.1163 -8.2558 0.1163 2 -8.2558 6

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-13 20:39:00 -0500 2021-01-11 S 12,480 $25.42 d 2,064,875 indirect yes -0.5033 -2.6713 0.0 1 -8.3624 5

SAUER PAUL - Officer SVP PROCESS DEV, MANUFACTURING

2021-01-12 21:43:01 -0500 2021-01-11 S 973 $25.38 d 79,426 direct yes 0.1163 -8.2558 0.1163 2 -8.2558 6

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-08 S 31,468 $26.43 d 2,086,499 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-08 S 200 $28.23 d 2,077,355 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-08 S 8,944 $27.08 d 2,077,555 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-07 S 24,524 $27.75 d 2,141,023 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-07 S 469 $29.51 d 2,117,967 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-07 S 22,587 $28.80 d 2,118,436 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-06 S 34,913 $29.24 d 2,188,054 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

HOPFNER ROBERT LORNE - Director by pivotal bioventure partners fund i, l.p.

2021-01-08 17:17:36 -0500 2021-01-06 S 22,507 $29.99 d 2,165,547 indirect yes -3.0201 -3.9896 0.0 1 -4.176 5

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
VAXCYTE INC PCVX 2021-03-03 20:15:03 UTC -0.5019 0.5719 100000
VAXCYTE INC PCVX 2021-03-03 19:45:03 UTC -0.5019 0.5719 100000
VAXCYTE INC PCVX 2021-03-03 19:15:02 UTC -0.5019 0.5719 100000
VAXCYTE INC PCVX 2021-03-03 18:45:03 UTC -0.503 0.573 100000
VAXCYTE INC PCVX 2021-03-03 18:15:04 UTC -0.503 0.573 100000
VAXCYTE INC PCVX 2021-03-03 17:45:02 UTC -0.503 0.573 100000
VAXCYTE INC PCVX 2021-03-03 17:15:03 UTC -0.503 0.573 100000
VAXCYTE INC PCVX 2021-03-03 16:45:03 UTC -0.5031 0.5731 100000
VAXCYTE INC PCVX 2021-03-03 16:15:04 UTC -0.5031 0.5731 100000
VAXCYTE INC PCVX 2021-03-03 15:45:03 UTC -0.5031 0.5731 100000
VAXCYTE INC PCVX 2021-03-03 15:15:03 UTC -0.5031 0.5731 100000
VAXCYTE INC PCVX 2021-03-03 14:45:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-03 14:15:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-03 13:45:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-03 13:15:04 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-03 12:45:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-02 22:15:02 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-02 21:45:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-02 21:15:03 UTC -0.4897 0.5597 100000
VAXCYTE INC PCVX 2021-03-02 20:45:03 UTC -0.4916 0.5616 100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Series Portfolios Trust- Weiss Alternative Balanced Risk Fund PCVX -18.0 shares, $-672.66 2020-10-31 N-PORT

Elevate your investments